Publication:
Pharmacotherapy of depression in Thailand: Country report 1999

dc.contributor.authorC. Sukyingen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-09-07T09:22:16Z
dc.date.available2018-09-07T09:22:16Z
dc.date.issued2000-02-01en_US
dc.description.abstractThailand has a population of approximately 61 million. The prevalence of mental disorders among the population in Bangkok was 21.3%, with approximately one-fifth being depressive disorders. A study on the patterns of psychotropic drug prescriptions by general practitioners indicated that only one-third of primary care attenders received any psychiatric treatments. Amitryptyline was the most commonly used antidepressants (96.7%). The National Drug Committee policy encourages general practitioners to use only drugs available from the National List of Essential Drugs. The economic crisis in the region has also worsened the situation. The Department of Mental Health has recently developed the practice guideline on the care of patients with mood disorders.en_US
dc.identifier.citationSingapore Medical Journal. Vol.41, No.3 SUPPL. 1 (2000), 53-54en_US
dc.identifier.issn00375675en_US
dc.identifier.other2-s2.0-0034090012en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/26286
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0034090012&origin=inwarden_US
dc.subjectMedicineen_US
dc.titlePharmacotherapy of depression in Thailand: Country report 1999en_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0034090012&origin=inwarden_US

Files

Collections